«If our findings are confirmed by additional studies, they may open doors to the development of targeted
therapies against the tumor subtypes more likely to affect African Americans and potentially help reduce racial disparities in breast cancer.»
Not exact matches
On its own, this immune response had no immediate effect in the fight
against the utilized breast
tumors, but in combination with the ADC it proved itself effective in attacking cancer cells in mice, resulting in the complete cure of the majority of mice receiving the combination
therapy.
They then tried adoptive T cell
therapy (ACT), in which T cells directed
against a
tumor are infused into a patient.
«Genes may cause
tumor aggressiveness, drug resistance in African - American prostate cancer: Research found many targeted
therapies for prostate cancer may not be effective
against tumors in African - American men.»
The authors said their results, which they have made publicly available, constitute an invaluable resource to help clinicians predict which chemotherapies will be most effective
against tumor cells with particular genetic mutations, and how to rationally combine
therapies to prevent cancers from developing resistance.
By viewing this fusion as another disease imposed onto
tumor cells, scientists could devise new
therapies against metastasis, the researchers say in the May Nature Reviews Cancer.
In their report that has received advance online publication in Nature Nanotechnology, a research team based at the Wellman Center for Photomedicine at Massachusetts General Hospital (MGH) describes how a nanomedicine that combines photodynamic
therapy — the use of light to trigger a chemical reaction — with a molecular
therapy drug targeted
against common treatment resistance pathways reduced a thousand-fold the dosage of the molecular
therapy drug required to suppress
tumor progression and metastatic outgrowth in an animal model.
By tracking and understanding which host cell pathways are manipulated by these T. gondii proteins, scientists can identify potential new targets to develop more effective
therapies against highly aggressive solid
tumors.
Orchestrating a successful immune attack
against tumors has proven difficult so far, but a new study from MIT suggests that such
therapies could be improved by simultaneously activating both arms of the immune system.
Because the vaccine causes the body to mount an immune response directed
against a unique
tumor, the
therapy is much more effective than gene - targeted or more general chemotherapy alone.
New research out of the University of Michigan supports combining two approaches to fight back
against gliomas: attacking the
tumor with gene
therapy while enhancing the immune system's ability to fight it, too.
Experimental
therapies using T cells taken from the bloodstream have not, however, worked very well
against solid
tumors.
Therapies based on immune cells, which target particular
tumor molecules, are more specific, but they are not effective
against a variety of
tumors.
The safe use of a stem - cell - based
therapy against brain metastasis would require preventing the engineered cells from persisting within the brain, where they could affect normal tissue and possibly give rise to new
tumors.
As demonstrated by the breadth of clinical trial involvement shown above, CCIR members are testing the utility of immune checkpoint blockade in lymphoma (shown by Dr. Allison to be effective
against melanoma), genetic engineering in cell
therapy (e.g., CD19, CXCR2, TGF - β DNR), and TLR agonists or IL - 2 in vaccine formulations as well as some novel combination
therapies, such as the infusion of
tumor - reactive lymphocytes from HLA - matched donors who were vaccinated with a lymphoma idiotype.
Our researchers have identified a bacterial - based
therapy for attacking pancreatic
tumors, offering hope in the fight
against one of the deadliest cancers.
Yet cancer metabolism, like everything else that happens in
tumors, is very complex, and a
therapy that's effective
against one metabolic process may not work
against another.
New research into CAR - T cell
therapy has revealed crucial mechanisms that could help the immunotherapy technique, which is currently only effective
against blood cancers, be adapted for the treatment of brain
tumors and other forms of solid cancers.
Our experts leveraged enormous amounts of
tumor profiling data to identify the validated
therapies that are most likely to be effective
against this subtype of NSCLC.
Low - dose chemotherapy, radiation, or targeted
therapies given in combination with immune checkpoint blockade may prove to be an effective and efficient way to immunize the body
against tumor cells,» says CRI Scientific Advisory Council associate director James P. Allison, Ph.D., who identified the first immune checkpoint blockade with his discovery in 1995 that the cytotoxic T lymphocyte antigen - 4 (CTLA - 4) receptor inhibited T cell responses.
By exploiting these differences, scientists have developed
therapies that target specific
tumor types, and these targeted
therapies have proven useful
against most breast cancers.
The American Council on Exercise advises
against wave
therapy for those who are pregnant, have a history of seizures, blood clotting issues,
tumors, or people with pacemakers.
The authors noted that the efficacy of vitamin C
therapy could not be judged when oral doses were given — but stated that vitamin C «may indeed be effective
against tumors when administered intravenously.»
Radiation
therapy can help extend the lives of affected dogs, but also is ineffective
against tumor cells that have metastasized.